Urticaria and Angioedema
Editat de Torsten Zuberbier, Clive Grattan, Marcus Maureren Limba Engleză Paperback – 23 aug 2016
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (2) | 645.18 lei 39-44 zile | |
Springer International Publishing – 27 oct 2022 | 645.18 lei 39-44 zile | |
Springer Berlin, Heidelberg – 23 aug 2016 | 765.61 lei 6-8 săpt. | |
Hardback (1) | 842.75 lei 39-44 zile | |
Springer International Publishing – 26 oct 2021 | 842.75 lei 39-44 zile |
Preț: 765.61 lei
Preț vechi: 805.91 lei
-5% Nou
Puncte Express: 1148
Preț estimativ în valută:
146.50€ • 159.78$ • 123.53£
146.50€ • 159.78$ • 123.53£
Carte tipărită la comandă
Livrare economică 24 aprilie-08 mai
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783662500927
ISBN-10: 3662500922
Pagini: 158
Ilustrații: X, 158 p.
Dimensiuni: 155 x 235 mm
Greutate: 0.25 kg
Ediția:Softcover reprint of the original 1st ed. 2010
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
ISBN-10: 3662500922
Pagini: 158
Ilustrații: X, 158 p.
Dimensiuni: 155 x 235 mm
Greutate: 0.25 kg
Ediția:Softcover reprint of the original 1st ed. 2010
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
Cuprins
History of Urticaria.- Aetiopathogenesis of Urticaria.- Classification of Urticaria.- Impact of Urticaria: QOL and Performance.- Acute Urticaria.- Chronic Urticaria.- Dermographic and Delayed Pressure Urticaria.- Heat and Cold Urticaria.- Solar Urticaria.- Cholinergic Urticaria and Exercise-Induced Anaphylaxis.- Contact Urticaria.- Urticarial Syndromes and Autoinflammation.- Urticaria Vasculitis.- Angioedema.- Therapy of Urticaria.- Standard Operating Procedures: A Practical Approach.
Recenzii
From the reviews:“A terrific reference on the pathogenesis, differential diagnosis, and treatment of urticaria and angioedema. Each chapter has a table summarizing the important highlights. … The purpose is to provide current information on the treatment and pathogenesis of urticaria. This objective is nicely fulfilled. The audience is dermatologists, particularly clinical dermatologists. … This is undoubtedly the best book I have read on urticaria … . Learning about urticaria and angioedema is unbelievably easy if you study this book. … This is a thumbs-up purchase.” (Patricia Wong, Doody’s Review Service, June, 2010)
Textul de pe ultima copertă
Urticaria and Angioedema provides a practical, comprehensive review of all types and aspects of urticaria and angioedema important to the clinician. Its content is completely up-to-date—taking into consideration both current guidelines and all recent literature—and
USPs:
This guide offers invaluable assistance in the daily practical management of urticaria patients.
It highlights the current knowledge about pathophysiology, and focuses on the clinically relevant aspects of diagnosis and treatment.
It includes a full range of standard operating procedures, as well as patient information leaflets in a copy-ready format.
Written by internationally renowned experts.
- highlights current knowledge about pathophysiology
- focuses on the clinically relevant aspects of diagnosis and treatment
- includes a full range of standard operating procedures
- features patient information leaflets in a copy-ready format
- offers indispensable assistance in the daily practical management of urticaria patients
USPs:
This guide offers invaluable assistance in the daily practical management of urticaria patients.
It highlights the current knowledge about pathophysiology, and focuses on the clinically relevant aspects of diagnosis and treatment.
It includes a full range of standard operating procedures, as well as patient information leaflets in a copy-ready format.
Written by internationally renowned experts.
Caracteristici
This guide offers invaluable assistance in the daily practical management of urticaria patients It highlights the current knowledge about pathophysiology, and focuses on the clinically relevant aspects of diagnosis and treatment It includes a full range of standard operating procedures, as well as patient information leaflets in a copy-ready format Written by internationally renowned experts Includes supplementary material: sn.pub/extras
Notă biografică
Torsten Zuberbier is Professor at Charité Berlin and President of the Global Allergy and Asthma European Network (GA²LEN). In addition, he is chairman of the European Centre for Allergy Research Foundation (ECARF). Prof. Zuberbier completed his clinical and scientific education in the field of dermatology at the Charité Virchow Klinikum and wrote his post-doctoral dissertation on the differentiation and function of human mast cells. In 2003, he was appointed Head of Allergy and Co-Director of the Department of Dermatology and Allergy at the Charité Berlin. Prof. Zuberbier’s research focuses on urticaria since 1990, initiating systematic guidelines from 2000 onwards. Further research interest is, airways allergies, atopic eczema, food allergies and human mast cells. He has published more than 500 papers and is a member of numerous scientific bodies.
Clive Grattan, MA, MD, FRCP, is Consultant Dermatologist at St John’s Institute of Dermatology, London. He has led the difficulturticaria clinic at St Thomas’ Hospital for 15 years. He has had a clinical and research interest in urticaria since the 1980’s, including original studies on chronic autoimmune urticaria pathogenesis and management. He was the first to describe the autologous serum skin test response in chronic idiopathic urticarial and was awarded a Doctorate of Medicine by Cambridge University for his thesis. First author of the first revisions of the British Association of Dermatology guidelines on urticarial, he currently undertakes clinical research in chronic urticaria and mastocytosis and teaches extensively, has written many contributions and spoken on these topics worldwide. He has been EiC of Clinical and Translational Allergy, journal of the EAACI, was chairman of the Dermatology section and a member of the Executive Committee member of the EAACI, President of the Dermatology section of the R.S. of Medicine and a council member of the British Society of Allergy and Clinical Immunology. Hehas had longstanding involvement with the regulatory aspects of medicine doing committee work for the UK Health Dept., the Medicines Regulatory Healthcare Authority, the European Medicines Agency and the National Institute of Clinical Excellence. Current clinical practice includes all aspects of adult Dermatology with a special interest in Cutaneous Allergy.
Marcus Maurer is Professor of Dermatology and Allergy at the Allergie-Centrum-Charité in Berlin, Germany. He trained in dermatology and allergology in Berlin and Mainz, and in experimental pathology at the Beth Israel Deaconess Hospital and Harvard Medical School in Boston from 1995 to 1998, prior to attaining his board certification for dermatology in 2000 and allergology in 2003. He has made numerous important contributions to our understanding of the role of mast cells in the pathogenesis of chronic inflammatory disorders as well as in protection from infections. His clinical emphasis is on urticaria, pruritus, and auto-inflammatory syndromes. M. Maurer is the author of over 390 publications in peer-reviewed journals including Nature and the NEJ of Medicine. Over several years, Prof. Maurer’s team has established national reference centers for the investigation and treatment of urticaria, mastocytosis, hereditary angioedema, angioedema and other mast cell-driven diseases, and has conducted more than 30 randomized controlled trials (phase I through IV) since 2011.
Clive Grattan, MA, MD, FRCP, is Consultant Dermatologist at St John’s Institute of Dermatology, London. He has led the difficulturticaria clinic at St Thomas’ Hospital for 15 years. He has had a clinical and research interest in urticaria since the 1980’s, including original studies on chronic autoimmune urticaria pathogenesis and management. He was the first to describe the autologous serum skin test response in chronic idiopathic urticarial and was awarded a Doctorate of Medicine by Cambridge University for his thesis. First author of the first revisions of the British Association of Dermatology guidelines on urticarial, he currently undertakes clinical research in chronic urticaria and mastocytosis and teaches extensively, has written many contributions and spoken on these topics worldwide. He has been EiC of Clinical and Translational Allergy, journal of the EAACI, was chairman of the Dermatology section and a member of the Executive Committee member of the EAACI, President of the Dermatology section of the R.S. of Medicine and a council member of the British Society of Allergy and Clinical Immunology. Hehas had longstanding involvement with the regulatory aspects of medicine doing committee work for the UK Health Dept., the Medicines Regulatory Healthcare Authority, the European Medicines Agency and the National Institute of Clinical Excellence. Current clinical practice includes all aspects of adult Dermatology with a special interest in Cutaneous Allergy.
Marcus Maurer is Professor of Dermatology and Allergy at the Allergie-Centrum-Charité in Berlin, Germany. He trained in dermatology and allergology in Berlin and Mainz, and in experimental pathology at the Beth Israel Deaconess Hospital and Harvard Medical School in Boston from 1995 to 1998, prior to attaining his board certification for dermatology in 2000 and allergology in 2003. He has made numerous important contributions to our understanding of the role of mast cells in the pathogenesis of chronic inflammatory disorders as well as in protection from infections. His clinical emphasis is on urticaria, pruritus, and auto-inflammatory syndromes. M. Maurer is the author of over 390 publications in peer-reviewed journals including Nature and the NEJ of Medicine. Over several years, Prof. Maurer’s team has established national reference centers for the investigation and treatment of urticaria, mastocytosis, hereditary angioedema, angioedema and other mast cell-driven diseases, and has conducted more than 30 randomized controlled trials (phase I through IV) since 2011.